Navigation Links
Marc J. Fagel of the U.S. Securities and Exchange Commission to Discuss SEC Enforcement at CBI's Biotech/Pharma Finance and Accounting Forum in San Francisco
Date:10/7/2009

BOSTON, Oct. 7 /PRNewswire/ -- The Center for Business Intelligence (CBI), a division of Advanstar Communications, is pleased to announce the full agenda for the upcoming Biotech/Pharma Finance and Accounting Forum in San Francisco on November 19, 2009. Marc J. Fagel, Regional Director of the San Francisco Regional Office at the U.S. Securities and Exchange Commission, is the most recent addition to the program's elite faculty and will address SEC enforcement and the review process.

This comprehensive one-day forum delves into the accounting and biotech financial reporting issues that matter most during these tough economic times and, in addition to the SEC, will include presentations from firms such as Cell Genesys, Affymax, BioMarin Pharmaceuticals, Monogram Biosciences, Inc., Oncomed and Poniard Pharmaceuticals. Over 2,400 executives have attended CBI's Pharmaceutical Accounting and Financial Reporting Congress since its inception more than five years ago, and this year's San Francisco program has been specifically designed for innovative life science companies.

Other opportune session topics include:

  • Taking the Pulse on the Economy and Chief Financial Challenges/Opportunities for Today's Biotech Companies
  • Wall Street Address: Creating Value and Securing Capital for Life Science Companies in a Strained Economy
  • Collaborative R&D Deals, Revenue Recognition and Accounting for Multiple Arrangements - Update on EITFs 08-1, 08-9 and 00-21
  • CFO Strategies and Capital Raising in a Tough Economy

CBI's west coast forum is sponsored by PricewaterhouseCoopers, Duff & Phelps, OUM & Co LLP and KPMG. To view the full agenda, please visit http://www.cbinet.com/agendawest. If you would like to apply for a press pass, please contact Erica Kirwan of CBI at 339.298.2263.

About CBI:

A subsidiary of Advanstar Communications, CBI Research, Inc. offers Pharmaceutical and Healthcare conferences that serve senior executives and government officials by providing a unique platform for highly focused content and ideal networking opportunities with senior policy- and decision-makers. CBI events provide you with concrete, real-life examples that you can begin to apply at your organization immediately for significant impact on costs and revenue. For more information, please visit http://www.cbinet.com.

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.

SOURCE The Center for Business Intelligence


'/>"/>
SOURCE The Center for Business Intelligence
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
2. NuVasive to Present at the JMP Securities Healthcare Focus Conference
3. InterMune to Present at JMP Securities Conference
4. NeurogesX to Present at JMP Securities Healthcare Focus Conference
5. Echo Therapeutics to Present at 4th Annual JMP Securities Healthcare Conference
6. Alexza Pharmaceuticals to Present at the Fourth Annual JMP Securities Healthcare Focus Conference
7. BioCryst to Present at JMP Securities Healthcare Conference
8. Researcher Investigates Disparities in Doctor-Patient Information Exchange During Clinical Trial Offers
9. Wedgewood Introduces Refresh(TM) Exchange-Program: Free Exchange of Expired Veterinary Compounded Medications Solves Key Industry Problem
10. Impact Medical Solutions Announces Initiation of Pilot Clinical Trial and Listing on Frankfurt Stock Exchange
11. D-Pharm Raises NIS 85 Million in Rights Offering and Initial Public Offering (IPO) on the Tel Aviv Stock Exchange (TASE)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... , Dec. 6, 2016 /PRNewswire/ - InMed Pharmaceuticals, ... today on its R&D program in the use ... pulmonary disease (COPD). In June, 2015 InMed initiated ... to identify the targets and potential active compounds ... COPD. Subsequently, with in vitro assays using human ...
(Date:12/5/2016)... WARSAW, Ind. , Dec. 5, 2016  Zimmer ... "Company") today announced that, pursuant to its previously-announced ... securities identified in the table below (collectively, the ... Notes were validly tendered and not validly withdrawn ... York City time, today, December 5, ...
(Date:12/5/2016)... 5, 2016 Sangamo BioSciences, Inc. (Nasdaq: ... presentation of preclinical and manufacturing data that support SB-525, its ... Annual Meeting of the American Society of Hematology (ASH) ... from December 3-6, 2016. "We have developed an ... we believe is highly competitive, and we remain on track ...
Breaking Medicine Technology:
(Date:12/6/2016)... Albuquerque, NM (PRWEB) , ... December 06, 2016 ... ... awarded JumpStart Autism Center with an Award of Distinction, recognizing the organization as ... needs providers that excel in the areas of clinical quality, staff satisfaction and ...
(Date:12/6/2016)... ... December 06, 2016 , ... Gateway Analytical, ... offering HIAC particle counting and sizing services for USP 788 and 789 particulate ... new service as a response to the needs of pharmaceutical and medical device ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... November 25th, when SevenPoint2 released the much-anticipated HydroFX for Water®. This first-of-its-kind ... design. Featuring one of the world’s most powerful antioxidants, molecular hydrogen, HydroFX ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... of the newly updated International Audit Protocol Consortium (IAPC) EHS audit protocol for ... protocols to understand the scope of their EHS regulatory obligations and rapidly collect, ...
(Date:12/6/2016)... Georgia (PRWEB) , ... December 06, 2016 , ... ... consecutive year to "Training" magazine’s 2017 Training Top 125 for their industry leading ... This prestigious, annual award recognizes USA as among the global elite in employer-sponsored ...
Breaking Medicine News(10 mins):